Search

Publications

LATEST PUBLICATIONS

  • Hibbert B, Macdougall A, Labinaz M, O'Brien ER, So DY, Dick A, Glover C, Froeschl M, Marquis JF, Wells GA, Blondeau M, Le May MR. Bivalirudin for Primary Percutaneous Coronary Interventions: Outcome Assessment in the Ottawa STEMI Registry.  Circ Cardiovasc Interv. 2012 Nov 13.
  • Le May MR, Wells GA, So DY, Glover CA, Froeschl M, Maloney J, Dionne R, Marquis JF, O'Brien ER, Dick A, Sherrard HL, Trickett J, Poirier P, Blondeau M, Bernick J, Labinaz M.  Reduction in mortality as a result of direct transport from the field to a receiving center for primary percutaneous coronary intervention. J Am Coll Cardiol. 2012 Oct 2;60(14):1223-30. doi: 10.1016/j.jacc.2012.07.008.
  • Maze R, Le May MR, Hibbert B, So DY, Froeschl M, Glover CA, Dick A, Marquis JF, Blondeau M, Labinaz M.  The impact of therapeutic hypothermia as adjunctive therapy in a regional primary PCI program.  Resuscitation. 2012 Aug 21. doi:pii: S0300-9572(12)00398-X. 10.1016/j.resuscitation.2012.08.002. [Epub ahead of print]
  • Hibbert B, Simard T, Wilson KR, Hawken S, Wells GA, Ramirez FD, Le May MR, So DY, Glover CA, Froeschl M, Marquis JF, Labinaz M, Dick A, O'Brien ER.  Transradial versus transfemoral artery approach for coronary angiography and percutaneous coronary intervention in the extremely obese.  JACC Cardiovasc Interv. 2012 Aug;5(8):819-26. doi: 10.1016/j.jcin.2012.04.009.
  • So DYF, Roberts JD. “Overcoming Obstacles in Pharmacogenomic Strategies for Antiplatelet Drugs – Are We RAPID enough?” Pharmacogenomics July 2012; 13(10):1105-8
  • Roberts JD, Wells GA, Le May MR, Labinaz M, Glover C, Froeschl M, Dick A, Marquis JF, O’Brien E, Goncalves S, Druce I, Stewart A, Gollob MH, So DYF. “Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomized, proof-of-concept trial.” Lancet. 2012 May 5; 379(9827):1705-11. Epub 2012 Mar 29.
  • Tu JV, Ko DT, Guo H, Richards JA, Walton N, Natarajan MK, Wijeysundera HC, So D, Latter DA, Feindel CM, Kingsbury K, Cohen EA; for the Cardiac Care Network of Ontario’s Variations in Revascularization Practice in Ontario Working Group. “Determinants of variations in coronary revascularization practices.” CMAJ. 2012 Feb 7;184(2):179-186. Epub 2011 Dec 12.
  • Roberts JD, So DY, Lambert AS, Ruel M. “Successful surgical repair of ventricular double rupture.” Can J Cardiol. 2011 Nov;27(6):868.e5-7.
  • Simard T, Hibbert B, Chong AY, Ruchin P, Le May M, Labinaz M, Froeschl M, So D, Glover C, Marquis JF, O'Brien E.” Unprotected left main coronary artery stenting with zotarolimus (Endeavor) drug-eluting stents: A Single Center Retrospective Experience.” Catheter Cardiovasc Interv. 2011 Jul 29. doi: 10.1002/ccd.23244. [Epub ahead of print]
  • Ko DT, Atzema CL, Donovan LR, Graham MM, Huynh T, So DY, Wang J, Wijeysundera HC, Tu JV. “ Rescue percutaneous coronary interventions for failed fibrinolytic therapy in ST-segment elevation myocardial infarction: a population-based study.” Am Heart J. 2011 Apr;161(4):764-770.e1.

PAPERS IN REFEREED JOURNALS

  • So DY, Cook EF, Le May M, Glover C, Williams W, Ha A, Davie RF, Froeschl M, Marquis JF, O'Brien E, Labinaz M. "Association of Aspirin Dosage to Clinical Outcomes after Percutaneous Coronary Intervention: Observations from the Ottawa Heart Institute PCI Registry" J Inv Cardiol 2009 Mar (in press).
  • Ko DT, Donovan LR, Huynh T, Rinfret S, So DY, Love MP, Galbraith D, Tu JV; Canadian Cardiovascular Outcomes Research Team (CCORT)A survey of primary percutaneous coronary intervention for patients with ST segment elevation myocardial infarction in Canadian hospitals. Can J Cardiol. 2008 Nov;24(11):839-43.
  • Le May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells GA, Davies RF, Sherrard HL, Maloney J, Marquis JF, O'Brien ER, Trickett J, Poirer P, Ryan SC, Ha A, Joseph PG, Labinaz M. "A Citywide Protocol for Primary PCI in ST-segment Elevation Myocardial Infarction". N Engl J Med. 2008. 358(3):231-40.
  • Chow BJ, Dennie C, Hoffmann U, So D, de Kemp RA, Ruddy TD, Beanlands RS. "Comparison of Computed Tomographic Angiography versus Ribidium-82 Positron Emission Tomography for the Detection of Patients with Anatomical Coronary Artery Disease. Can J Cardiol.2007.23(10):801-7.
  • Le May MR, Davies RF, Dionne R, Maloney J, Trickett J, So D, Ha A, Sherrard H, Glover C, Marquis JF, O'Brien ER, Stiell IG, Poirier P, Labinaz M. "Comparison of Early Mortality of Paramedic-diagnosed ST-segment Elevation Myocardial Infarction with Immediate Transport to a Designated Primary Percutaneous Coronary Intervention Center to that of Similar Patients Transported to the Nearest Hospital. Am J Cardiol. 2006. 98(10):1329-33.
  • So D, Ha A, Turek M, Maloney J, Higginson L, Davies RF, Ryan S, Le May M. "Comparison of Mortality Patterns in Patients with ST-Elevation Myocardial Infarction Arriving by Emergency Medical Services versus Self-Transport (From the Prospective Ottawa Hospital STEMI Registry)". Am J Cardiol 2006. 97(4):458-61.
  • Wolfsohn AL, So DY, Chan K, Burwash I , Hendry P, Veinot JP, Labinaz M. "Thrombus of the Ascending Aorta: A Rare Case of Myocardial Infarction. Cardiovasc Pathol. 2005.14(4):214-8.
  • Le May M, Kurdi M, Labinaz M, Glover, C, So D, Davies RF. "Safety of Coronary Stenting with Eptifibatide and Ultra-Low-Dose Heparin". Am J Cardiol 2005. 95:630-32.
  • So D, Mesena T, Stinson W, Veinot J. "Intra-aortic Balloon Pump Related Thrombi of the Abdominal Aorta Resulting in Visceral Ischaemia. Pathology 2003. 35(6):536-8.